CIMINO, Luca
 Distribuzione geografica
Continente #
NA - Nord America 7.279
EU - Europa 2.356
AS - Asia 1.888
SA - Sud America 51
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
Totale 11.596
Nazione #
US - Stati Uniti d'America 7.244
SG - Singapore 616
GB - Regno Unito 548
CN - Cina 542
IT - Italia 541
HK - Hong Kong 525
SE - Svezia 469
RU - Federazione Russa 162
DE - Germania 155
BG - Bulgaria 150
UA - Ucraina 94
FI - Finlandia 83
TR - Turchia 66
ID - Indonesia 58
FR - Francia 46
IE - Irlanda 20
BR - Brasile 18
BZ - Belize 16
ES - Italia 15
NL - Olanda 15
CZ - Repubblica Ceca 14
IN - India 14
MY - Malesia 14
JP - Giappone 13
PE - Perù 12
CL - Cile 9
LT - Lituania 9
CA - Canada 8
IR - Iran 8
BE - Belgio 7
IL - Israele 7
CO - Colombia 6
IQ - Iraq 6
PL - Polonia 6
EU - Europa 5
GT - Guatemala 5
AU - Australia 4
EG - Egitto 4
AR - Argentina 3
AT - Austria 3
CH - Svizzera 3
CY - Cipro 3
MA - Marocco 3
PT - Portogallo 3
RO - Romania 3
SI - Slovenia 3
VN - Vietnam 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
GL - Groenlandia 2
HU - Ungheria 2
KR - Corea 2
KZ - Kazakistan 2
MN - Mongolia 2
NO - Norvegia 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
BS - Bahamas 1
DK - Danimarca 1
DZ - Algeria 1
KE - Kenya 1
KG - Kirghizistan 1
LV - Lettonia 1
MK - Macedonia 1
NG - Nigeria 1
PA - Panama 1
PK - Pakistan 1
PR - Porto Rico 1
SA - Arabia Saudita 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 11.596
Città #
Santa Clara 1.554
Fairfield 906
Ashburn 559
Hong Kong 521
Singapore 492
Chandler 459
Houston 443
Woodbridge 443
Nyköping 386
Southend 364
Seattle 340
Cambridge 299
Wilmington 291
Ann Arbor 227
Beijing 185
Princeton 173
Jacksonville 163
Sofia 150
San Diego 147
Dearborn 139
Modena 132
New York 93
Moscow 81
London 64
Jakarta 54
Helsinki 49
Shanghai 39
Eugene 38
Rome 32
Milan 31
San Jose 31
Izmir 27
Dublin 20
Munich 19
Kilburn 17
Belize City 16
Redwood City 15
Frankfurt am Main 13
Los Angeles 13
Chiswick 12
Kuala Lumpur 12
Boardman 11
Bologna 11
Buffalo 11
Dallas 11
Falls Church 11
Brno 10
Guangzhou 10
Turin 10
Bremen 9
Norwalk 9
Pamplona 9
Amsterdam 8
Edinburgh 8
Genoa 8
Lima 8
Alba Adriatica 7
Brussels 7
Hanover 7
Hounslow 7
Las Vegas 7
Nanjing 7
Padova 7
Paris 7
Prescot 7
Quarrata 7
Reggio Emilia 7
Reggio Nell'emilia 7
Wuhan 7
Lappeenranta 6
Reggio Calabria 6
Tokyo 6
Florence 5
Francavilla al Mare 5
Guatemala City 5
Hefei 5
Islington 5
Santiago 5
Southwark 5
Stockholm 5
São Paulo 5
Tel Aviv 5
Verona 5
Acton 4
Atlanta 4
Bengaluru 4
Brescia 4
Chicago 4
Gravina di Catania 4
Poviglio 4
Vigevano 4
Washington 4
Baltimore 3
Barcelona 3
Bergamo 3
Cape Town 3
Central 3
Columbus 3
Coriano 3
Hangzhou 3
Totale 9.417
Nome #
G/R 241 polymorphism of intercellular adhesion molecule 1 (ICAM-1) is associated with Fuchs uveitis 221
-463 G/A myeloperoxidase promoter polymorphism in giant cell arteritis 204
Interferon Alpha-2a for the Treatment of Post-Infectious Uveitis Secondary to Presumed Intraocular Tuberculosis 203
Visual loss and other cranial ischaemic complications in giant cell arteritis 201
Histopathologic Findings of Patients With Biopsy-Negative Giant Cell Arteritis Compared to Those Without Arteritis: A Population-Based Study 197
Higher Frequencies of Lymphocytes Expressing the Natural Killer Group 2D Receptor in Patients With Behçet Disease 195
Comparison between colour duplex sonography findings and different histological patterns of temporal artery 192
Correlations between histopathological findings and clinical manifestations in biopsy-proven giant cell arteritis 188
Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study 187
Is colour duplex sonography-guided temporal artery biopsy useful in the diagnosis of giant cell arteritis? A randomized study 185
Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease 184
Long-term remission in biopsy proven giant cell arteritis: A retrospective cohort study 181
Increased expression of interleukin-22 in patients with giant cell arteritis 179
MicroRNA markers of inflammation and remodelling in temporal arteries from patients with giant cell arteritis 179
Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis 171
anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumab 168
Erratum to: Changes in patterns of uveitis at a tertiary referral center in Northern Italy: analysis of 990 consecutive cases 166
Interleukin-10 promoter polymorphisms in giant cell arteritis 166
Tuberculous uveitis, a resurgent and underdiagnosed disease 165
Small-vessel vasculitis surrounding an uninflamed temporal artery and isolated vasa vasorum vasculitis of the temporal artery: two subsets of giant cell arteritis 165
Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study 165
Adalimumab in the treatment of immune-mediated diseases 163
Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis 163
The causes of uveitis in a referral centre of Northern Italy 162
Searching for viral antibodies and genome in intraocular fluids of patients with Fuchs uveitis and non-infectious uveitis 160
PlA1/A2 polymorphism of the platelet glycoprotein receptor IIIA and risk of cranial ischemic complications in giant cell arteritis 160
Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study 152
Standardization of red flags for referral to rheumatologists and ophthalmologists in patients with rheumatic diseases and ocular involvement: a consensus statement 149
The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases 145
Ophthalmic manifestations of cat scratch disease 145
Flares in Biopsy-Proven Giant Cell Arteritis in Northern Italy: Characteristics and Predictors in a Long-Term Follow-Up Study 136
The therapeutic potential of tuftsin-phosphorylcholine in giant cell arteritis 127
Quasi cieco all'improvviso 113
Toll-like receptor 4 (TLR4) gene polymorphisms in giant cell arteritis 113
Anterior ischaemic optic neuropathy in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome): a case report and review of the literature 110
Association Between Specimen Length and Number of Sections and Diagnostic Yield of Temporal Artery Biopsy for Giant Cell Arteritis 104
Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia 104
Distribution patterns of 18F-fluorodeoxyglucose in large vessels of Takayasu's and giant cell arteritis using positron emission tomography 103
Interleukin-6 promoter polymorphism at position -174 in giant cell arteritis 102
Assessment of disease activity in large-vessel vasculitis: Results of an international delphi exercise 95
Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: A population-based study 84
Cataract Surgery with Intraocular Lens Implantation in Juvenile Idiopathic Arthritis-Associated Uveitis: Outcomes in the Era of Biological Therapy 82
Testo-atlante sulle Uveiti 81
Cutaneous Involvement in Diseases with Plasma Cell Differentiation: Diagnostic Approach 81
Assessment and classification of choroidal vasculitis in posterior uveitis using indocyanine green angiography 79
Effectiveness of Infliximab and Interferon Alpha-2a for the Treatment of Behçet’s Uveitis: Customizing Therapy according to the Clinical Features 77
Ebv-driven lymphoproliferative disorders and lymphomas of the gastrointestinal tract: A spectrum of entities with a common denominator (part 3) 77
Clinical Relevance of Subcentimetric Lymph Node Biopsy in the Diagnosis of Ocular Sarcoidosis 75
Interferon Alpha-2a Treatment for Post-Uveitic Refractory Macular Edema 74
Assessment of the Anti-inflammatory Effects of NORFLO® ORO in Acute Relapses of HLA-B27-associated Autoimmune Uveitis: A Multicenter, Randomized, Placebo-controlled, Double-blind Clinical Study 71
Cytokine Profiling in Aqueous Humor Samples From Patients With Non-Infectious Uveitis Associated With Systemic Inflammatory Diseases 69
Vogt–Koyanagi–Harada patients show higher frequencies of circulating NKG2Dpos NK and NK T cells 68
Relapses and long-term remission in large vessel giant cell arteritis in northern Italy: Characteristics and predictors in a long-term follow-up study 67
Clinical Features and Prevalence of Spondyloarthritis in a Cohort of Italian Patients Presenting with Acute Nongranulomatous Anterior Uveitis 67
Uveitis and other ocular complications following covid-19 vaccination 67
Ebv-driven lymphoproliferative disorders and lymphomas of the gastrointestinal tract: A spectrum of entities with a common denominator (part 2) 66
Survival and Recurrence in Vitreoretinal Lymphoma Simulating Uveitis at Presentation: The Possible Role of Combined Chemotherapy 65
Efficacy of Rituximab Treatment in Vogt-Koyanagi-Harada Disease Poorly Controlled by Traditional Immunosuppressive Treatment 63
Autoimmune uveitis in children: clinical correlation between antinuclear antibody positivity and ocular recurrences 63
Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative 62
Changes in patterns of uveitis at a tertiary referral center in Northern Italy: analysis of 990 consecutive cases 60
Uveitis in Tumor Patients Treated with Immunological Checkpoint- and Signal Transduction Pathway-Inhibitors 58
Abatacept for Severe Anti-Tumor Necrosis Factor alpha Refractory Juvenile Idiopathic Arthritis-Related Uveitis 57
Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis—Report 2: Guidelines for Initiating Antitubercular Therapy in Anterior Uveitis, Intermediate Uveitis, Panuveitis, and Retinal Vasculitis 57
Ocular inflammatory events following COVID-19 vaccination: a multinational case series 57
Cogan’s syndrome 56
Acute zonal occult outer retinopathy complex disease: Lessons learned about choroid, photoreceptors, and retinal function 56
Bromfenac ophthalmic solution 0.09% as an adjunctive therapy to topical steroids after cataract surgery in pseudoexfoliation syndrome 55
Infantile-Onset Spinocerebellar Ataxia Type 5 (SCA5) with Optic Atrophy and Peripheral Neuropathy 55
Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial 54
Assessement and classification of choroidal vasculitis in intraocular inflammation using indocyanine green angiography 53
Aqueous tap and rapid diagnosis of cytomegalovirus anterior uveitis: the Reggio Emilia experience 52
Interleukin-6 expression in inflamed and non-inflamed temporal arteries from patients with giant cell arteritis 51
Anterior Chamber Inflammation After Cataract Surgery: A Randomized Clinical Trial Comparing Bromfenac 0.09% to Dexamethasone 0.1% 51
Sensitivity of indocyanine green angiography for the follow-up of active inflammatory choriocapillaropathies 51
Beta-adrenergic antagonists in the treatment of glaucoma 50
Differential inflammatory involvement in retina and choroid in birdshot chorioretinopathy 50
Fluorescein angiography findings in eyes with lamellar macular hole and epiretinal membrane foveoschisis 50
Surgical management of post-uveitic epiretinal membranes 50
Retinocoroidopatia tipo Birdshot 49
Unilateral Ocular Pseudopemphigoid in a Patient With Glaucoma 48
Twenty-four Month Outcomes in the Collaborative Ocular Tuberculosis Study (COTS)-1: Defining the "Cure" in Ocular Tuberculosis 48
Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis—Report 1: Guidelines for Initiating Antitubercular Therapy in Tubercular Choroiditis 48
Changes in contrast sensitivity after surgically-induced reduction of IOP in human subjects 47
Aqueous Humor Analysis in Overlapping Clinical Diagnosis of Cytomegalovirus and Rubella Virus Anterior Uveitis 46
Cogan syndrome 46
From A… to… Z(OOR): The Clinical Spectrum of Acute Zonal Occult Outer Retinopathy 46
Uveitis and internuclear ophthalmoplegia as ocular manifestations of sarcoidosis 46
Latanoprost versus bimatoprost [6] (multiple letters) 46
Deep sclerectomy without absorbable implant and with unsutured superficial flap: Prospective randomized clinical trial vs. trabeculectomy with releasable sutures 45
Diagnosis and Treatment of Listeria monocytogenes Endophthalmitis: A Systematic Review 45
Effect of brimonidine on intraocular pressure in normal tension glaucoma: A short term clinical trial 44
Clinical features and outcomes of patients with tubercular uveitis treated with antitubercular therapy in the collaborative ocular tuberculosis study (COTS)-1 44
Measuring Anterior Chamber Inflammation After Cataract Surgery: A Review of the Literature Focusing on the Correlation with Cystoid Macular Edema 43
Bronchial reactivity in healthy individuals undergoing long-term topical treatment with beta-blockers 43
Scoring of dual fluorescein and ICG inflammatory angiographic signs for the grading of posterior segment inflammation (dual fluorescein and ICG angiographic scoring system for uveitis) 43
67-Galium (67Ga) Scan in Sarcoid Uveitis 42
Parnaparin versus aspirin in the treatment of retinal vein occlusion. A randomized, double blind, controlled study 42
Improvement of spatial contrast sensitivity threshold after surgical reduction of intraocular pressure in unilateral high-tension glaucoma 42
Choroidal Vascular Changes in Multiple Evanescent White Dot Syndrome 42
Totale 9.774
Categoria #
all - tutte 79.734
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.734


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020973 0 0 0 0 0 240 240 161 152 70 78 32
2020/20211.340 100 70 85 149 169 90 106 173 84 132 96 86
2021/20221.865 47 92 97 58 19 67 449 59 197 53 443 284
2022/20231.776 278 178 176 93 147 219 34 171 203 23 110 144
2023/20241.788 35 73 74 100 390 131 66 225 296 97 56 245
2024/20252.539 95 46 75 337 1.158 828 0 0 0 0 0 0
Totale 11.845